tradingkey.logo
搜尋

WGRX

WGRX
添加自選
2.980USD
-0.090-2.93%
收盤 07/02, 13:00美東報價延遲15分鐘
301.90M總市值
虧損本益比TTM

TradingKey WGRX股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Wellgistics Health Inc當前公司基本面數據相對謹慎,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名159/204位。機構持股佔比非常高,中期看,股價處於上升通道。近一個月,市場表現非常差,但技術面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

WGRX評分

相關信息

行業排名
159 / 204
全市場排名
478 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

WGRX亮點

亮點風險
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
業績增長期
公司處於發展階段,最新年度總收入23.34M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入23.34M美元
估值低估
公司最新PE估值-3.40,處於3年歷史低位
史蒂文·科恩持倉
明星投資者史蒂文·科恩持倉,最新持倉15.25股

分析師目標

基於 0 分析師
--
評級
--
目標均價
--
漲幅空間